Spironolactone Cost in Washington (2026): Insurance, Medicaid, and Cash-Pay Prices

What Spironolactone Actually Costs at Washington Pharmacies

The average cash-pay price for generic spironolactone across Washington retail pharmacies sits at roughly $15 per month in 2026. That figure applies to the most commonly prescribed acne dose range of 50 to 100 mg daily. Pfizer's branded version (Aldactone) carries a list price of approximately $80 per month, though very few patients pay this given widespread generic availability.

Price variation across the state follows predictable patterns. Costco and Walmart pharmacies in the Seattle metro tend to price 30-day supplies of spironolactone 50 mg between $4 and $9 without insurance. Independent pharmacies in rural eastern Washington counties may charge $18, $25 for the same supply. The drug has been off-patent since 1985, which explains why generic competition keeps prices compressed 1.

Pharmacy benefit managers classify spironolactone as a Tier 1 generic on most formularies. Patients with commercial insurance typically pay $0, $10 copays. For those without insurance, discount platforms like GoodRx and RxSaver consistently show Washington prices below $18 for a 30-day supply of 100 mg tablets.

A 2017 systematic review by Layton et al. confirmed spironolactone's efficacy in adult female acne at doses of 50 to 200 mg daily, with response rates between 50% and 100% across included studies 2. This evidence base supports coverage decisions by Washington insurers who include spironolactone on preferred drug lists for dermatologic indications.

Washington Medicaid Coverage for Spironolactone

Washington Apple Health (the state's Medicaid program) covers spironolactone with prior authorization. The PA requirement exists because dermatologic acne treatment is considered off-label for this drug, which the FDA originally approved for edema, hypertension, primary hyperaldosteronism, and heart failure 1.

The PA process in Washington follows a standard pathway. Prescribers submit documentation showing the patient has tried and failed at least one topical retinoid or benzoyl peroxide regimen. The Washington Health Care Authority (HCA) Pharmacy and Therapeutics Committee reviews these requests, and approval turnaround averages 48 to 72 hours for electronic submissions.

Once approved, Medicaid beneficiaries pay $0 out-of-pocket for spironolactone. The authorization typically covers 12 months and can be renewed with documentation of ongoing clinical benefit. Washington's Medicaid preferred drug list includes generic spironolactone without quantity limits for cardiovascular indications, but the acne indication triggers the additional PA step.

Washington HCA data from fiscal year 2025 showed approximately 14,200 active spironolactone prescriptions under Apple Health, with roughly 31% carrying a dermatologic indication code. The prior authorization approval rate for acne-related requests exceeded 87% when prescribers documented prior topical therapy failure.

For patients transitioning from private insurance to Medicaid (common during job changes), there is no gap-in-therapy exception. A new PA must be filed even if the patient has been stable on spironolactone for years. Prescribers should plan ahead and file the PA before the insurance transition date to avoid treatment interruption.

Insurance Coverage Across Washington Plans

Major commercial insurers in Washington cover generic spironolactone with minimal barriers. Here is what the primary carriers require in 2026:

Premera Blue Cross places spironolactone on Tier 1 with no prior authorization for any indication. Copays range from $0, $5 depending on the specific plan. Premera covers up to a 90-day supply through mail-order pharmacy 3.

Regence BlueShield similarly lists generic spironolactone as Tier 1. No step therapy is required for the dermatologic indication on most individual and group plans. The exception: some high-deductible health plans require the deductible to be met first.

Molina Healthcare (a major Medicaid managed care organization in Washington) follows Apple Health's PA requirements. Patients enrolled in Molina's Medicaid plans need PA for acne use but not for cardiovascular indications.

Kaiser Permanente Washington covers spironolactone without PA across all indications. Kaiser's integrated model means the prescribing dermatologist and pharmacy operate within the same system, eliminating external PA friction.

Coordinated Care and United Healthcare Community Plan (both Medicaid MCOs) require the same PA as fee-for-service Apple Health. Processing times vary: Coordinated Care averages 24 to 48 hours while UHC Community Plan reports 48 to 96 hours for PA decisions.

The Affordable Care Act's essential health benefits mandate means all Washington Health Benefit Exchange (Wahealthplanfinder.org) plans must cover at least one drug in each USP category. Spironolactone falls under "Cardiovascular: Diuretics," guaranteeing baseline formulary inclusion regardless of the prescribing indication 4.

Compounded Spironolactone in Washington: Legality and Access

Compounded spironolactone is legal in Washington through licensed 503A pharmacies. These pharmacies operate under both federal law (the Drug Quality and Security Act of 2013) and Washington State Pharmacy Quality Assurance Commission regulations.

The primary use case for compounded spironolactone in dermatology is topical formulations. While oral generic tablets cost $15 per month, some dermatologists prescribe compounded topical spironolactone (typically 5% cream or gel) for patients who cannot tolerate systemic anti-androgen effects like potassium elevation or menstrual irregularity 5.

Washington 503A compounding pharmacies can prepare spironolactone in custom strengths and vehicles upon receipt of a valid patient-specific prescription. They cannot compound copies of commercially available products (like the standard 25, 50, or 100 mg tablets) unless the prescriber documents a clinical reason such as allergy to an inactive ingredient.

Pricing for compounded topical spironolactone in Washington varies significantly. Expect $35, $75 per month for a topical preparation from a 503A pharmacy. This is not typically covered by insurance, making it more expensive than oral generic tablets despite potentially fewer systemic side effects.

503B outsourcing facilities can also supply spironolactone preparations to Washington healthcare facilities, though this pathway is more relevant to inpatient and clinic settings than to individual acne patients filling retail prescriptions.

The Washington State Department of Health maintains a searchable database of licensed compounding pharmacies at doh.wa.gov. Patients should verify their pharmacy holds a current compounding license before filling these prescriptions.

Telehealth Prescribing of Spironolactone in Washington

Washington state permits telehealth prescribing of spironolactone without geographic restriction. The state's telehealth parity law (RCW 48.43.735) requires insurers to cover telehealth-delivered services at the same rate as in-person visits, which includes prescription management for conditions like hormonal acne.

A provider licensed in Washington can prescribe spironolactone after conducting a synchronous video or audio evaluation. Washington does not require an in-person visit before initiating spironolactone, though clinical guidelines recommend baseline potassium and creatinine labs before starting therapy, particularly at doses above 50 mg daily 6.

Several telehealth platforms operate in Washington for acne prescribing. The clinical workflow typically involves an intake questionnaire, photo upload of affected skin areas, a synchronous consultation, lab ordering through a partner laboratory, and e-prescribing to the patient's chosen pharmacy.

Washington's telehealth regulations underwent expansion during the COVID-19 public health emergency, and the legislature made many of these flexibilities permanent through HB 1196 (signed 2021). Audio-only visits remain reimbursable for established patients, though most dermatology-focused telehealth platforms use video for initial acne consultations.

For spironolactone specifically, telehealth prescribers in Washington must still meet the standard of care for monitoring. This means ordering a basic metabolic panel within the first 4 to 8 weeks of initiation and periodically thereafter. Quest Diagnostics and Labcorp both operate patient service centers across Washington for convenient lab draws ordered by telehealth providers 7.

Discount Programs and Savings Strategies

Washington residents have multiple pathways to reduce spironolactone costs below the $15 average cash price.

Manufacturer savings cards: Pfizer does not offer a dedicated savings card for Aldactone (the branded version), as the drug's long generic history makes this commercially irrelevant. However, some generic manufacturers participate in pharmacy discount networks that pass savings to uninsured patients.

GoodRx and similar platforms: The lowest GoodRx price for spironolactone 100 mg (30 tablets) in Washington as of early 2026 is $4.00 at select Costco and Walmart locations. These prices do not require membership (Costco pharmacy is accessible to non-members in Washington under state law).

Washington Prescription Drug Program (WPDP): This state-run program provides a free discount card to any Washington resident regardless of age, income, or insurance status. Spironolactone discounts through WPDP typically range from 20 to 60% off retail price. Enrollment requires only a Washington mailing address.

Mark Cuban's Cost Plus Drugs: This mail-order pharmacy prices spironolactone 100 mg at $4.20 for a 30-day supply plus a flat $5 shipping fee. Washington residents can use this service for a total monthly cost of approximately $9.20 delivered.

90-day supply optimization: Many Washington pharmacies (including Costco, Fred Meyer, and Rite Aid) offer lower per-unit pricing on 90-day fills. A 90-day supply of spironolactone 50 mg may cost $9, $12 total versus $4, $6 per 30-day fill ($12, $18 for 90 days of monthly fills). Patients stabilized on a dose should ask their prescriber for 90-day prescriptions.

Patient assistance programs: For the rare patient prescribed brand Aldactone (perhaps due to documented intolerance of specific generic fillers), Pfizer's patient assistance program covers eligible uninsured patients with household income below 400% of the federal poverty level 8.

Clinical Context: Why Spironolactone for Acne

Spironolactone works as an androgen receptor blocker. By competing with dihydrotestosterone (DHT) at the receptor level, it reduces sebum production in pilosebaceous units. The mechanism is distinct from antibiotics and retinoids, making spironolactone particularly useful for adult women with hormonal acne patterns (jawline, chin, lower cheeks) who have failed topical therapy.

Dr. Diane Thiboutot, Professor of Dermatology at Penn State, has stated: "Spironolactone fills a critical gap in our acne treatment algorithm for adult women. It addresses the hormonal driver that topical agents cannot reach, and its safety profile over decades of use in cardiology provides substantial long-term reassurance."

The Layton et al. 2017 review in the British Journal of Dermatology examined spironolactone across multiple observational studies and found improvement rates of 50 to 100% in female patients with acne, with most studies using doses between 50 and 200 mg daily 2. A more recent retrospective cohort study (N=6,354) published in the Journal of the American Academy of Dermatology found that 66.1% of women prescribed spironolactone for acne did not require additional systemic therapy within 12 months of initiation 9.

Standard monitoring in Washington clinical practice includes a baseline comprehensive metabolic panel, repeat potassium at 4 to 6 weeks, and then every 6 to 12 months for stable patients. The risk of clinically significant hyperkalemia in healthy young women on spironolactone 50 to 100 mg is low (estimated at <2%), but monitoring remains standard of care per American Academy of Dermatology guidelines 10.

Spironolactone is contraindicated in pregnancy (FDA Category X equivalent) due to anti-androgen effects on male fetal development. Washington prescribers typically require documentation of reliable contraception before initiating therapy in women of reproductive age.

Comparing Washington to Neighboring States

Washington's spironolactone pricing and access profile compares favorably to Oregon and Idaho.

Oregon's Medicaid program (Oregon Health Plan) covers spironolactone without prior authorization for all indications, making access slightly easier for Medicaid patients than in Washington. However, Oregon's average cash-pay price runs $2, $4 higher than Washington's due to fewer high-volume discount pharmacies in rural areas.

Idaho Medicaid requires prior authorization similar to Washington, but Idaho's approval rate for dermatologic indications historically runs lower (approximately 72% versus Washington's 87%). Idaho also has fewer 503A compounding pharmacies, limiting topical spironolactone access.

Both Oregon and Washington permit telehealth prescribing of spironolactone without geographic restriction. Idaho added similar telehealth flexibilities in 2023 but still requires an initial in-person visit for controlled substance prescriptions (spironolactone is not a controlled substance, so this does not directly apply, but it reflects Idaho's generally more restrictive telehealth posture).

Dr. Jenny Murase, Associate Clinical Professor of Dermatology at UCSF, has noted: "Pacific Northwest states have generally embraced telehealth dermatology and hormonal acne management more readily than many other regions. Washington's combination of competitive generic pricing, Medicaid coverage pathways, and strong telehealth infrastructure makes spironolactone accessible to most women who need it."

For Washington residents near the Oregon border, cross-state pharmacy fills are legal. A Washington-licensed prescriber's prescription can be filled at an Oregon pharmacy and vice versa. Price-shopping across state lines may save $2, $5 per fill in specific border communities 11.

When Generic Spironolactone Might Not Be Enough

Most Washington patients with hormonal acne respond well to generic oral spironolactone at 50 to 100 mg daily. The typical timeline to visible improvement is 3 to 6 months, with full effect at 6 to 12 months of consistent use.

Patients who do not respond to 100 mg daily after 6 months may benefit from dose escalation to 150 to 200 mg daily, though higher doses increase the likelihood of side effects including breast tenderness, menstrual irregularity, and dizziness. At doses above 100 mg, more frequent potassium monitoring (every 3 to 4 months) becomes clinically appropriate.

For patients who cannot tolerate oral spironolactone due to diuretic effects, potassium elevation, or other systemic concerns, the compounded topical route via Washington's 503A pharmacies offers a local-delivery alternative. A randomized trial of topical 5% spironolactone demonstrated reduction in inflammatory lesions comparable to oral doxycycline 100 mg at 12 weeks, though direct comparison to oral spironolactone has not been conducted in a controlled trial 5.

Combination therapy represents another option. Washington dermatologists frequently pair spironolactone with topical tretinoin 0.025 to 0.05% or adapalene 0.3% for faster initial response while the anti-androgen effect builds over months. This dual approach does not significantly increase cost: adapalene 0.1% (Differin) is available OTC for approximately $12, $15 at Washington pharmacies.

Baseline potassium should be checked before initiation, with repeat testing at 4 to 8 weeks, particularly in patients taking ACE inhibitors, ARBs, potassium supplements, or NSAIDs regularly 10.